Research and Innovation Centre officially opens
Monday 11th September 2017
Trust Chair Linda Pollard officially opened the new Research and Innovation Centre at St James’s Hospital on Friday. Its location near the main entrance to the St James's site puts Research and Innovation at our front door, making an important statement about our strategic intentions.
The centre will provide a real focus for research and innovation throughout our hospitals and collaboration with our partners in academia and industry.
Research, Innovation and Education are fundamental to our goals and strategy. It is well-evidenced that where hospitals are active in research, patients get better treatment and this new facility will help us consolidate and improve our impressive performance in clinical trials and other vital research.
Outside is the Yorkshire Brain Research garden which won a silver gilt award at the Harrogate Spring Flower Show, and was funded by the Yorkshire Brain Research charity. The garden celebrates the amazing architecture and wonders of the brain, representing the vitality and health of the brain, a state that the research teams aim to preserve in their research into the many complex brain disorders including epilepsy, Parkinson’s disease, multiple sclerosis and dementia. It also includes medicinal plants of historical and health importance in brain and cognition which are interwoven in the key areas.
We are also delighted to announce that our Trust, working alongside the University of Leeds, has been chosen by the National Institute for Health Research (NIHR) to host two out of 11 ground-breaking national co-operatives from January 2018.
We are one of only three centres in the country to be successful in our bid to deliver an NIHR Medical Technology and In Vitro Diagnostic Co-operative (MIC).
In vitro diagnostics are tests that can detect diseases, conditions or infections. The MICs will support companies developing in vitro diagnostics for cancer, musculoskeletal, renal and infectious diseases in generating evidence required to bring new products to market. Expertise available to industrial partners will include support for designing and running clinical trials, health economic evaluations, biomarker validation, and health informatics.
Our second programme will be the NIHR Surgical MedTech Co-operative and will provide support for companies developing new medical devices for use in surgical procedures across gastroenterology, vascular and colorectal diseases.
Expertise available to industrial partners will include engineering support for medical device and robotic technology development, nanotechnology development, biosensor development, support for designing and running clinical evaluations, and health economic assessments of innovative devices.